Westmount, Canada Clinical Trials

A listing of Westmount, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 55 clinical trials
SAR408701 Versus Docetaxel in Previously Treated Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients

Primary Objectives: Study is designed with two primary endpoints that will be analyzed on randomized participants at the time of the cutoff date for each given analysis (progressive free survival [PFS] and overall survival [OS]). Study success is defined either on PFS or OS The primary objective is to determine …

metastasis
pulmonary metastasis
stage iv non-small cell lung cancer
cancer
small cell lung cancer
Investigational Site Number 1240003
 (5.3 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +168 other locations
A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients

Primary Objective: To determine the effect of venglustat on the rate of total kidney volume (TKV) growth (Stage and estimated glomerular filtration rate (eGFR) decline in patients at risk of rapidly progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD) (Stage 2). Secondary Objectives: To determine the effect of venglustat on the …

ophthalmological examination
urine osmolality
treatment regimen
cyst
tolvaptan
Investigational Site Number 1240003
 (6.2 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +80 other locations
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)

Primary Objective: To determine whether SAR439859 per os improves progression free survival (PFS) when compared with a endocrine monotherapy of the choice of the physician, in participants with metastatic or locally advanced breast cancer. Secondary Objectives: To compare the overall survival in the 2 treatment arms To assess the objective …

endocrine therapy
ESR1
tamoxifen
breast cancer
cancer metastatic
Investigational Site Number 1240006
 (1.8 away) Contact site
  • 0 views
  • 04 Dec, 2020
  • +125 other locations
SAR408701 Versus Docetaxel in Previously Treated Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small Cell Lung Cancer Patients  

Primary Objectives: Study is designed with two primary endpoints that will be analyzed on randomized participants at the time of the cutoff date for each given analysis (progressive free survival [PFS] and overall survival [OS]). Study success is defined either on PFS or OS The primary objective is to determine …

metastasis
pulmonary metastasis
stage iv non-small cell lung cancer
cancer
small cell lung cancer
Investigational Site Number 1240003
 (5.3 away)
  • 0 views
  • 21 Dec, 2020
  • +51 other locations
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease  

This is a multicenter, randomized, double-blind, placebo-controlled study that will evaluate the efficacy and safety of intravenous (IV) prasinezumab versus placebo in participants with Early Parkinson's Disease (PD) who are on stable symptomatic PD medication.

early parkinson's
parkinsonism
bradykinesia
resting tremor
tremor
Montreal Neurological Institute and Hospital
 (1.8 away)
  • 0 views
  • 28 Jun, 2022
  • +125 other locations
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

This study is being done to see if tucatinib with ado-trastuzumab emtansine (T-DM1) works better than T-DM1 alone to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma. The breast cancer in this study is either metastatic (spread into other parts of the body) …

Jewish General Hospital
 (1.8 away) Contact site
  • 0 views
  • 14 Mar, 2022
  • +227 other locations
A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme (INTRAGO II) (INTRAGO-II)

INTRAGO II resembles a multicentric, prospective, randomized, 2-arm, open-label clinical phase III trial which tests if the median progression-free survival (PFS) of patients with newly diagnosed glioblastoma multiforme (GBM) can be improved by the addition of intraoperative radiotherapy (IORT) to standard radiochemotherapy.

Montreal Neurological Institute and Hospital
 (1.8 away) Contact site
  • 0 views
  • 20 Jul, 2022
  • +16 other locations
Comparison of the Erector Spinae Plane Block Versus Intrathecal Morphine on Post-Cesarean Delivery Analgesia

This study is a Randomized Control Trial comparing the Erector Spinae Plane Block with intrathecal morphine for post cesarean delivery analgesia.

Royal Victoria Hospital
 (1.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Safety Tolerability and Immunogenicinity of a Coronavirus-Like Particle COVID-19 Vaccine in Adults Aged 18-55 Years.

The study will be a randomized, partially-blinded, prime-boost, staggered dose-escalation Phase 1 study intended to assess the safety, tolerability, and immunogenicity of the Coronavirus-Like Particle COVID-19 Vaccine at three dose levels (3.75 g, 7.5 g, and 15 g VLP) unadjuvanted or adjuvanted with either CpG 1018 or AS03 in healthy …

hormonal contraception
coronavirus infection
acute respiratory syndrome (sars)
estrogen
hysterectomy
Syneos Health
 (1.8 away) Contact site
  • 0 views
  • 01 Feb, 2023
  • +1 other locations
A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardiovascular risk.

cardiovascular disease
dulaglutide
tirzepatide
body mass index
ViaCar Recherche Clinique
 (5.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +650 other locations